What Is A Breast Needle Biopsy Procedure?

https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812

The Breast Needle Biopsy Procedure​ is a cornerstone of the modern diagnostic pathway for breast diseases. It involves the percutaneous acquisition of tissue samples from suspicious breast lesions under imaging guidance (Ultrasound, Mammography, or MRI) for pathological analysis. The widespread adoption of this technique signifies the transition of breast diagnostics from "exploratory open surgery" to the era of "precision minimally invasive medicine."

1. Technological Evolution: From Blind to Precise

Early breast biopsies relied on clinical palpation, which was ineffective for non-palpable lesions (e.g., microcalcifications). With advances in imaging, breast biopsy has evolved through three distinct stages:

• Fine Needle Aspiration (FNA):​ Utilizes a 22–25G thin needle to aspirate cells for cytology, but cannot assess tissue architecture.
• Core Needle Biopsy (CNB):​ Employs a 14–16G hollow-core needle to obtain "cylindrical" tissue cores. It is currently the most widely used definitive diagnostic tool.
• Vacuum-Assisted Biopsy (VAB):​ Exemplified by systems like Mammotome® or EnCor®, utilizing negative pressure suction and a rotary cutting blade. Allows for the acquisition of multiple large specimens through a single insertion, ideal for microcalcifications and multiple small lesions.

2. Core Operational Workflow

A standard breast needle biopsy procedure includes:

• Pre-procedural Localization:​ Real-time ultrasound guidance (most common) or stereotactic localization (for calcifications).
• Local Anesthesia:​ Typically 1% Lidocaine, infiltrated thoroughly along the planned track and around the lesion.
• Puncture and Sampling:

CNB:Firing the biopsy gun to obtain 1–2 tissue cores.

VAB:Inserting the probe; using vacuum suction to draw tissue into the sampling chamber; rotary cutting; repeating until the lesion is largely or completely excised.

• Specimen Handling:​ Specimens are immediately placed in 10% Neutral Buffered Formalin​ and sent for routine paraffin embedding, H&E staining, and necessary immunohistochemistry (IHC).
• Post-procedure Compression:​ Following needle withdrawal, apply local compression dressings for 15–30 minutes to prevent hematoma formation.

3. Clinical Value and Significance

The breast needle biopsy is a "gold standard" for differentiating benign from malignant breast lesions. It spares benign disease patients from unnecessary open surgery and provides essential pathological subtyping for breast cancer patients prior to neoadjuvant chemotherapy. Furthermore, acquired specimens enable molecular testing (ER, PR, HER2, Ki-67), representing the critical first step toward "precision medicine" in breast cancer care.

4. Essential Instrumentation

A complete biopsy system typically includes:

• Biopsy Needle:​ The core component, usually made of medical-grade stainless steel or titanium alloy.
• Biopsy Gun:​ Provides the instantaneous firing mechanism (for CNB).
• Vacuum Driver:​ Generates continuous negative pressure (for VAB).
• Guide Grid/Probe:​ Used in conjunction with imaging equipment.
• Advancements continue toward even less invasive, smarter, and more comfortable procedures, including magnetic navigation biopsies and interventional MRI (iMRI)-guided biopsies.